Galecto Inc. has become the latest biotech company to launch on the NASDAQ, raising $85m with its initial public offering (IPO) on 30 October - and extending the sector's remarkable record-breaking run in 2020.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?